The Vaccines of the Future Are Developed at the Heart of Science
The Vaccines of the Future Are Developed at the Heart of Science
At High Biosafety, The Assurance of Vaccine R&D
At High Biosafety, The Assurance of Vaccine R&D
Areas
/assets/uploads/misyon_1751513202_848.webp
Areas

Vaccine Development
Virology Studies
Recombinant Protein Production
Monoclonal Antibody Production
Collaborative Studies
 

Detailed Information
Projects
/assets/uploads/laboratuvar_1751513189_965.webp
Projects

Preparation of an inactivated vaccine antigen against Crimean-Congo Hemorrhagic Fever, supported by Higher Education Institutions, conducted from 2013 to 2015.

Detailed Information
About Us
About Us Detailed Information
Partnerships
NEWS
Preclinical studies for the CCHF vaccine have reached the final stage.
Preclinical studies for the CCHF vaccine have reached the final stage. Detailed Information
Future scientists will be trained in the new building of the vaccine center where TURKOVAC is produced.
Future scientists will be trained in the new building of the vaccine center where TURKOVAC is produced. Detailed Information
After TURKOVAC, the next goal is a domestic CCHF vaccine.
After TURKOVAC, the next goal is a domestic CCHF vaccine. Detailed Information
TURKOVAC accepted in the international scientific community.
TURKOVAC accepted in the international scientific community. Detailed Information
TURKOVAC received emergency use authorization, mass production began.
TURKOVAC received emergency use authorization, mass production began. Detailed Information
Good news from TURKOVAC: Positive results in terms of safety and efficacy.
Good news from TURKOVAC: Positive results in terms of safety and efficacy. Detailed Information
The name of the domestic vaccine is TURCOVAC.
The name of the domestic vaccine is TURCOVAC. Detailed Information
Good news from TURKOVAC: Positive results in terms of safety and efficacy.
Good news from TURKOVAC: Positive results in terms of safety and efficacy. Detailed Information
The first dose of the Phase 2 trial of the COVID-19 vaccine candidate developed at Erciyes University was administered to volunteers.
The first dose of the Phase 2 trial of the COVID-19 vaccine candidate developed at Erciyes University was administered to volunteers. Detailed Information
The first dose of the domestic vaccine candidate was administered at Erciyes University.
The first dose of the domestic vaccine candidate was administered at Erciyes University. Detailed Information
COVID-19 vaccine trials on animals began at Erciyes University
COVID-19 vaccine trials on animals began at Erciyes University Detailed Information
COVID-19’s genetic map decoded at Erciyes University.
COVID-19’s genetic map decoded at Erciyes University. Detailed Information
Researchers at Erciyes University succeeded in isolating the coronavirus in cell culture.
Researchers at Erciyes University succeeded in isolating the coronavirus in cell culture. Detailed Information
Copyright © 2025 ERAGEM
Eliz Yazılım A.Ş.